Zhao Z, Liu X, Zong Y, Shi X, Sun Y
Viruses. 2024; 16(1).
PMID: 38275947
PMC: 10819745.
DOI: 10.3390/v16010012.
de Oliveira A, Fraefel C
Open Virol J. 2010; 4:109-22.
PMID: 20811580
PMC: 2930156.
DOI: 10.2174/1874357901004030109.
Kalamvoki M, Roizman B
Proc Natl Acad Sci U S A. 2009; 106(34):14576-80.
PMID: 19706544
PMC: 2732861.
DOI: 10.1073/pnas.0906905106.
Sydiskis R
J Virol. 1969; 4(3):283-91.
PMID: 16789105
PMC: 375870.
DOI: 10.1128/JVI.4.3.283-291.1969.
Aurelian L
J Virol. 1969; 4(3):197-202.
PMID: 16789092
PMC: 375857.
DOI: 10.1128/JVI.4.3.197-202.1969.
Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2.
Ank N, Petersen K, Malmgaard L, Mogensen S, Paludan S
J Virol. 2005; 79(15):9831-41.
PMID: 16014944
PMC: 1181601.
DOI: 10.1128/JVI.79.15.9831-9841.2005.
Herpes simplex virus type 1 immediate-early gene expression is required for the induction of apoptosis in human epithelial HEp-2 cells.
Sanfilippo C, Chirimuuta F, Blaho J
J Virol. 2003; 78(1):224-39.
PMID: 14671104
PMC: 303390.
DOI: 10.1128/jvi.78.1.224-239.2004.
Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a herpes simplex virus type 1 replication complex in a reconstituted system.
Ward P, Falkenberg M, Elias P, Weitzman M, Linden R
J Virol. 2001; 75(21):10250-8.
PMID: 11581393
PMC: 114599.
DOI: 10.1128/JVI.75.21.10250-10258.2001.
E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1.
Advani S, Weichselbaum R, Roizman B
J Virol. 2000; 74(17):7842-50.
PMID: 10933691
PMC: 112314.
DOI: 10.1128/jvi.74.17.7842-7850.2000.
The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes.
Advani S, Brandimarti R, Weichselbaum R, Roizman B
J Virol. 1999; 74(1):8-15.
PMID: 10590085
PMC: 111507.
Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1.
Aubert M, OToole J, Blaho J
J Virol. 1999; 73(12):10359-70.
PMID: 10559354
PMC: 113091.
DOI: 10.1128/JVI.73.12.10359-10370.1999.
The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells.
Aubert M, Blaho J
J Virol. 1999; 73(4):2803-13.
PMID: 10074128
PMC: 104038.
DOI: 10.1128/JVI.73.4.2803-2813.1999.
Association of herpes simplex virus regulatory protein ICP22 with transcriptional complexes containing EAP, ICP4, RNA polymerase II, and viral DNA requires posttranslational modification by the U(L)13 proteinkinase.
Leopardi R, Ward P, Ogle W, Roizman B
J Virol. 1997; 71(2):1133-9.
PMID: 8995634
PMC: 191165.
DOI: 10.1128/JVI.71.2.1133-1139.1997.
Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S.
Lu M, Shenk T
J Virol. 1996; 70(12):8850-7.
PMID: 8971013
PMC: 190981.
DOI: 10.1128/JVI.70.12.8850-8857.1996.
Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils.
Machida H, Sakata S, Kuninaka A, Yoshino H
Antimicrob Agents Chemother. 1981; 20(1):47-52.
PMID: 6269482
PMC: 181630.
DOI: 10.1128/AAC.20.1.47.
Molecular genetics of herpes simplex virus. VI. Characterization of a temperature-sensitive mutant defective in the expression of all early viral gene products.
Knipe D, Batterson W, Nosal C, Roizman B, Buchan A
J Virol. 1981; 38(2):539-47.
PMID: 6264126
PMC: 171184.
DOI: 10.1128/JVI.38.2.539-547.1981.
Tetrahydrouridine specifically facilitates deoxycytidine incorporation into herpes simplex virus DNA.
North T, Mathews C
J Virol. 1981; 37(3):987-93.
PMID: 6262539
PMC: 171096.
DOI: 10.1128/JVI.37.3.987-993.1981.
Molecular genetics of herpes simplex virus. VII. Characterization of a temperature-sensitive mutant produced by in vitro mutagenesis and defective in DNA synthesis and accumulation of gamma polypeptides.
Conley A, Knipe D, Jones P, Roizman B
J Virol. 1981; 37(1):191-206.
PMID: 6260973
PMC: 170996.
DOI: 10.1128/JVI.37.1.191-206.1981.
Antibody-mediated destruction of virus-infected cells.
Sissons J, Oldstone M
Adv Immunol. 1980; 29:209-60.
PMID: 6251708
PMC: 7173112.
DOI: 10.1016/s0065-2776(08)60045-0.
Herpes-type virus of the frog renal adenocarcinoma. I. Virus development in tumor transplants maintained at low temperature.
Stackpole C
J Virol. 1969; 4(1):75-93.
PMID: 5808113
PMC: 375840.
DOI: 10.1128/JVI.4.1.75-93.1969.
